Clinical Trial Update: The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of psyllium seed on body weight and metabolic syndrome indicators in overweight or obese patients with schizoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity
• Schizophrenia

Drugs mentioned

• Psyllium Seed (psyllium seed)

Snippet

Sponsor: Ru-Shin Zhang | Conditions: Overweight and Obesity, Metabolic Cardiovascular Syndrome | NA | Status: COMPLETED